Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (يفتح نافذة جديدة)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Source‎: Pediatr Transplant 2017;21(6):e13017.

مفهرسة‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (يفتح نافذة جديدة)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (يفتح نافذة جديدة)

Bhatia M, Davenport V, Cairo MS.

Source‎: Leuk Lymphoma 2007;48(1):9-15.

مفهرسة‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (يفتح نافذة جديدة)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (يفتح نافذة جديدة)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Source‎: Lancet 2003;361(9354):275-80.

مفهرسة‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (يفتح نافذة جديدة)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (يفتح نافذة جديدة)

Fassel H, Bussel JB, Roberts SS, Modak S

Source‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

مفهرسة‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (يفتح نافذة جديدة)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (يفتح نافذة جديدة)

Jacobson AE, Shah N, Setty BA

Source‎: Pediatr Blood Cancer 2017;64(8):e26473.

مفهرسة‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (يفتح نافذة جديدة)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (يفتح نافذة جديدة)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Source‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

مفهرسة‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (يفتح نافذة جديدة)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (يفتح نافذة جديدة)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Source‎: Int J Hematol 2015;102(5):626-32.

مفهرسة‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (يفتح نافذة جديدة)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (يفتح نافذة جديدة)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Source‎: J Pediatr 1996;129(5):656-60.

مفهرسة‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (يفتح نافذة جديدة)

Chemotherapy induced thrombocytopenia in pediatric oncology. (يفتح نافذة جديدة)

Tamamyan G, Danielyan S, Lambert MP

Source‎: Crit Rev Oncol Hematol 2016;99:299-307.

مفهرسة‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (يفتح نافذة جديدة)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (يفتح نافذة جديدة)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Source‎: Onkologie 2004;27(2):131-7.

مفهرسة‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (يفتح نافذة جديدة)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (يفتح نافذة جديدة)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Source‎: Ann Oncol 2005;16(1):139-45.

مفهرسة‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (يفتح نافذة جديدة)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (يفتح نافذة جديدة)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Source‎: Blood 1998;91(10):3601-6.

مفهرسة‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (يفتح نافذة جديدة)